BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34625796)

  • 1. Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation.
    Zha J; Kunselman LK; Xie HM; Ennis B; Shah YB; Qin X; Fan JM; Babushok DV; Olson TS
    Blood Adv; 2022 Jan; 6(1):108-120. PubMed ID: 34625796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioning.
    Ibrahim AA; Yahata T; Muguruma Y; Miyata T; Ando K
    Biochem Biophys Res Commun; 2019 Aug; 516(2):500-505. PubMed ID: 31230745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes.
    Zambetti NA; Bindels EM; Van Strien PM; Valkhof MG; Adisty MN; Hoogenboezem RM; Sanders MA; Rommens JM; Touw IP; Raaijmakers MH
    Haematologica; 2015 Oct; 100(10):1285-93. PubMed ID: 26185170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells.
    Bezzerri V; Bardelli D; Morini J; Vella A; Cesaro S; Sorio C; Biondi A; Danesino C; Farruggia P; Assael BM; D'amico G; Cipolli M
    Am J Hematol; 2018 Aug; 93(4):527-536. PubMed ID: 29285795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Wu L; Mo W; Zhang Y; Zhou M; Li Y; Zhou R; Xu S; Pan S; Deng H; Mao P; Wang S
    Int J Hematol; 2017 Jul; 106(1):71-81. PubMed ID: 28303517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
    Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
    Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.
    Rawls AS; Gregory AD; Woloszynek JR; Liu F; Link DC
    Blood; 2007 Oct; 110(7):2414-22. PubMed ID: 17638857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome.
    Joyce CE; Saadatpour A; Ruiz-Gutierrez M; Bolukbasi OV; Jiang L; Thomas DD; Young S; Hofmann I; Sieff CA; Myers KC; Whangbo J; Libermann TA; Nusbaum C; Yuan GC; Shimamura A; Novina CD
    J Clin Invest; 2019 Jun; 129(9):3821-3826. PubMed ID: 31211692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
    Kaur S; Sehgal A; Wu AC; Millard SM; Batoon L; Sandrock CJ; Ferrari-Cestari M; Levesque JP; Hume DA; Raggatt LJ; Pettit AR
    J Hematol Oncol; 2021 Jan; 14(1):3. PubMed ID: 33402221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation.
    Peci F; Dekker L; Pagliaro A; van Boxtel R; Nierkens S; Belderbos M
    Bone Marrow Transplant; 2022 Sep; 57(9):1357-1364. PubMed ID: 35690693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C protects the integrity of the bone marrow perivascular niche in mice.
    Fang S; Chen S; Nurmi H; Leppänen VM; Jeltsch M; Scadden D; Silberstein L; Mikkola H; Alitalo K
    Blood; 2020 Oct; 136(16):1871-1883. PubMed ID: 32842144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recovery of vascular niche in bone marrow by donor derived endothelial progenitor cells after allogeneic bone marrow transplantation in mice].
    Zhang Y; Song GL; Pan B; Hua J; Xu KL; Zeng LY
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):623-7. PubMed ID: 23134854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors.
    Hamabata T; Umeda K; Kouzuki K; Tanaka T; Daifu T; Nodomi S; Saida S; Kato I; Baba S; Hiramatsu H; Osawa M; Niwa A; Saito MK; Kamikubo Y; Adachi S; Hashii Y; Shimada A; Watanabe H; Osafune K; Okita K; Nakahata T; Watanabe K; Takita J; Heike T
    Sci Rep; 2020 Sep; 10(1):14859. PubMed ID: 32908229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.
    Raaijmakers MH; Mukherjee S; Guo S; Zhang S; Kobayashi T; Schoonmaker JA; Ebert BL; Al-Shahrour F; Hasserjian RP; Scadden EO; Aung Z; Matza M; Merkenschlager M; Lin C; Rommens JM; Scadden DT
    Nature; 2010 Apr; 464(7290):852-7. PubMed ID: 20305640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation.
    Yao Y; Song X; Cheng H; Tang G; Hu X; Zhou H; Wang J
    PLoS One; 2014; 9(8):e104607. PubMed ID: 25119573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).
    Cesaro S; Pillon M; Sauer M; Smiers F; Faraci M; de Heredia CD; Wynn R; Greil J; Locatelli F; Veys P; Uyttebroeck A; Ljungman P; Chevalier P; Ansari M; Badell I; Güngör T; Salim R; Tischer J; Tecchio C; Russell N; Chybicka A; Styczynski J; Krivan G; Smith O; Stein J; Afanasyev B; Pochon C; Menconi MC; Bosman P; Mauro M; Tridello G; de Latour RP; Dufour C
    Bone Marrow Transplant; 2020 Sep; 55(9):1796-1809. PubMed ID: 32203264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution.
    An N; Janech MG; Bland AM; Lazarchick J; Arthur JM; Kang Y
    Exp Hematol; 2013 Nov; 41(11):944-56. PubMed ID: 23994289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective.
    Hasan T; Pasala AR; Hassan D; Hanotaux J; Allan DS; Maganti HB
    Curr Oncol; 2024 Jan; 31(2):603-616. PubMed ID: 38392038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
    Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
    Front Immunol; 2021; 12():662048. PubMed ID: 34084166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.